Stocktoria
ARVINAS, INC. ARVN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-09-27
Chart by TradingView
4/9
Piotroski F — financial health
-1.73
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $262.6M | $263.4M | $78.5M | $131.4M | $53.6M |
| Operating income | -$118.5M | -$250.2M | -$401.5M | -$263.2M | -$188.4M |
| Net income | -$80.8M | -$198.9M | -$367.3M | -$282.5M | -$191.0M |
| Operating cash flow | -$273.8M | -$259.3M | -$347.8M | -$273.5M | $559.4M |
| Free cash flow | -$275.7M | -$261.1M | -$350.7M | -$280.3M | $554.7M |
| Total assets | $717.9M | $1.1B | $1.3B | $1.3B | $1.6B |
| Total liabilities | $284.0M | $529.7M | $644.6M | $703.9M | $799.9M |
| Shareholders' equity | $433.9M | $561.7M | $660.0M | $564.9M | $781.7M |
| Ratios | |||||
| Operating margin | -45.1% | -95.0% | -511.5% | -200.3% | -351.5% |
| Net margin | -30.8% | -75.5% | -467.9% | -215.0% | -356.3% |
| FCF margin | -105.0% | -99.1% | -446.8% | -213.3% | 1034.9% |
| Return on assets | -11.3% | -18.2% | -28.2% | -22.3% | -12.1% |
| Return on equity | -18.6% | -35.4% | -55.7% | -50.0% | -24.4% |
| Debt / equity | 0.00× | 0.00× | 0.00× | 0.00× | 0.00× |
| Current ratio | 4.92 | 4.64 | 4.98 | 4.20 | 5.93 |
| Revenue growth | -0.3% | 235.5% | -40.3% | 145.1% | 106.9% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 229,807 | $2.4M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.73 (distress)
- Working capital / assets 0.778
- Retained earnings / assets -2.246
- EBIT / assets -0.165
- Equity / liabilities 1.528
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001655759 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.